Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 2017 Jan 3;127(1):402. doi: 10.1172/JCI91882

Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility

Tsang-Chih Kuo, Ching-Ting Tan, Yi-Wen Chang, Chih-Chen Hong, Wei-Jiunn Lee, Min-Wei Chen, Yung-Ming Jeng, Jean Chiou, Pei Yu, Pai-Sheng Chen, Ming-Yang Wang, Michael Hsiao, Jen-Liang Su, Min-Liang Kuo
PMCID: PMC5199683  PMID: 28045406

Original citation: J Clin Invest. 2013;123(3):1082–1095. doi:10.1172/JCI64044.

Citation for this corrigendum: J Clin Invest. 2017;127(1):402. doi:10.1172/JCI91882.

During the assembly of Figure 3H, an incorrect image was inadvertently included for the CL1-5GL/ANGPTL1+pLKO_AS2.neo/SLUG sample in the lower panel. The correct tail vein injection panel is below.

graphic file with name jci-127-91882-g001.jpg

The authors regret the error.

Footnotes


Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES